Annual CFO
-$41.29 M
-$14.64 M-54.94%
31 March 2024
Summary:
LakeShore Biopharma annual cash flow from operations is currently -$41.29 million, with the most recent change of -$14.64 million (-54.94%) on 31 March 2024. During the last 3 years, it has fallen by -$4.90 million (-13.45%). LSB annual CFO is now -54.94% below its all-time high of -$26.65 million, reached on 31 March 2023.LSB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$20.15 M
0.00%
30 September 2023
Summary:
LakeShore Biopharma quarterly cash flow from operations is currently -$20.15 millionLSB quarterly CFO is now -28.54% below its all-time high of -$15.68 million, reached on 01 September 2022.LSB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$20.15 M
0.00%
30 September 2023
Summary:
LakeShore Biopharma TTM cash flow from operations is currently -$20.15 millionLSB TTM CFO is now -28.54% below its all-time high of -$15.68 million, reached on 01 September 2022.LSB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSB Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.9% | - | - |
| 3 y3 years | -13.4% | - | - |
| 5 y5 years | - | - | - |
LSB Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -54.9% | at low | -28.5% | at low | -28.5% | at low |
| 5 y | 5 years | -54.9% | at low | -28.5% | at low | -28.5% | at low |
| alltime | all time | -54.9% | at low | -28.5% | at low | -28.5% | at low |
LakeShore Biopharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$41.29 M(+54.9%) | - | - |
| Sept 2023 | - | -$20.15 M(+28.5%) | -$20.15 M(+28.5%) |
| Mar 2023 | -$26.65 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$15.68 M | -$15.68 M |
| Mar 2022 | -$27.02 M(-25.8%) | - | - |
| Mar 2021 | -$36.40 M | - | - |
FAQ
- What is LakeShore Biopharma annual cash flow from operations?
- What is the all time high annual CFO for LakeShore Biopharma?
- What is LakeShore Biopharma annual CFO year-on-year change?
- What is LakeShore Biopharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for LakeShore Biopharma?
- What is LakeShore Biopharma TTM cash flow from operations?
- What is the all time high TTM CFO for LakeShore Biopharma?
What is LakeShore Biopharma annual cash flow from operations?
The current annual CFO of LSB is -$41.29 M
What is the all time high annual CFO for LakeShore Biopharma?
LakeShore Biopharma all-time high annual cash flow from operations is -$26.65 M
What is LakeShore Biopharma annual CFO year-on-year change?
Over the past year, LSB annual cash flow from operations has changed by -$14.64 M (-54.94%)
What is LakeShore Biopharma quarterly cash flow from operations?
The current quarterly CFO of LSB is -$20.15 M
What is the all time high quarterly CFO for LakeShore Biopharma?
LakeShore Biopharma all-time high quarterly cash flow from operations is -$15.68 M
What is LakeShore Biopharma TTM cash flow from operations?
The current TTM CFO of LSB is -$20.15 M
What is the all time high TTM CFO for LakeShore Biopharma?
LakeShore Biopharma all-time high TTM cash flow from operations is -$15.68 M